The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

Kenji Kuwaki, Kazuhiro Nouso, Manabi Miyashita, Yasuhiro Makino, Hiroaki Hagihara, Akio Moriya, Takuya Adachi, Nozomu Wada, Yuki Yasunaka, Tetsuya Yasunaka, Yasuto Takeuchi, Hideki Ohnishi, Shinichiro Nakamura, Fusao Ikeda, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada

Research output: Contribution to journalArticle

Abstract

Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC.

Original languageEnglish
Pages (from-to)333-339
Number of pages7
JournalActa medica Okayama
Volume73
Issue number4
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Hepatocellular Carcinoma
Steroids
Safety
Control Groups
Fever
Hyperglycemia
Vomiting
Therapeutics

Keywords

  • antipyretic
  • hepatocellular carcinoma
  • steroid
  • therapeutic chemoembolization

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. / Kuwaki, Kenji; Nouso, Kazuhiro; Miyashita, Manabi; Makino, Yasuhiro; Hagihara, Hiroaki; Moriya, Akio; Adachi, Takuya; Wada, Nozomu; Yasunaka, Yuki; Yasunaka, Tetsuya; Takeuchi, Yasuto; Ohnishi, Hideki; Nakamura, Shinichiro; Ikeda, Fusao; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki.

In: Acta medica Okayama, Vol. 73, No. 4, 01.08.2019, p. 333-339.

Research output: Contribution to journalArticle

Kuwaki, Kenji ; Nouso, Kazuhiro ; Miyashita, Manabi ; Makino, Yasuhiro ; Hagihara, Hiroaki ; Moriya, Akio ; Adachi, Takuya ; Wada, Nozomu ; Yasunaka, Yuki ; Yasunaka, Tetsuya ; Takeuchi, Yasuto ; Ohnishi, Hideki ; Nakamura, Shinichiro ; Ikeda, Fusao ; Shiraha, Hidenori ; Takaki, Akinobu ; Okada, Hiroyuki. / The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. In: Acta medica Okayama. 2019 ; Vol. 73, No. 4. pp. 333-339.
@article{e9c4287998ee4d1ab49643aecc703737,
title = "The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma",
abstract = "Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC.",
keywords = "antipyretic, hepatocellular carcinoma, steroid, therapeutic chemoembolization",
author = "Kenji Kuwaki and Kazuhiro Nouso and Manabi Miyashita and Yasuhiro Makino and Hiroaki Hagihara and Akio Moriya and Takuya Adachi and Nozomu Wada and Yuki Yasunaka and Tetsuya Yasunaka and Yasuto Takeuchi and Hideki Ohnishi and Shinichiro Nakamura and Fusao Ikeda and Hidenori Shiraha and Akinobu Takaki and Hiroyuki Okada",
year = "2019",
month = "8",
day = "1",
doi = "10.18926/AMO/56935",
language = "English",
volume = "73",
pages = "333--339",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "4",

}

TY - JOUR

T1 - The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

AU - Kuwaki, Kenji

AU - Nouso, Kazuhiro

AU - Miyashita, Manabi

AU - Makino, Yasuhiro

AU - Hagihara, Hiroaki

AU - Moriya, Akio

AU - Adachi, Takuya

AU - Wada, Nozomu

AU - Yasunaka, Yuki

AU - Yasunaka, Tetsuya

AU - Takeuchi, Yasuto

AU - Ohnishi, Hideki

AU - Nakamura, Shinichiro

AU - Ikeda, Fusao

AU - Shiraha, Hidenori

AU - Takaki, Akinobu

AU - Okada, Hiroyuki

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC.

AB - Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC.

KW - antipyretic

KW - hepatocellular carcinoma

KW - steroid

KW - therapeutic chemoembolization

UR - http://www.scopus.com/inward/record.url?scp=85071509852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071509852&partnerID=8YFLogxK

U2 - 10.18926/AMO/56935

DO - 10.18926/AMO/56935

M3 - Article

VL - 73

SP - 333

EP - 339

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 4

ER -